Women and HIV Infection

6 For More Information About Trials NIAID provides major support for the AIDS Clinical Trials Information Service, at 1-800 -TRIALS-A, to advise callers as to the status of HIV clinical trials and drugs being studied throughout the United States. The service operates from 9 a.m. to 7 p.m. Eastern Time, Monday through Friday. NIAID, a component of the National Institutes of Health, supports investigators and scientific studies at universities, medical schools, hospitals and research institutions in the United States and abroad aimed at preventing, diagnosing and treating such illnesses as AIDS, tuberculosis, allergy, and asthma. NIH is an agency of the U.S. Public Health Service, part of the U.S. Department of Health and Human Services. Prepared by: Office of Communications NIAID, National Institutes of Health Bethesda, MD 20892 (301) 496-5717 June 1993

/ 6

Actions

file_download Download Options Download this page PDF - Pages 1-6 Image - Page 6 Plain Text - Page 6

About this Item

Title
Women and HIV Infection
Author
National Institute of Allergy and Infectious Diseases (U.S.)
Canvas
Page 6
Publication
National Institute of Allergy and Infectious Diseases (U.S.)
undated
Subject terms
reports
Item type:
reports

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0290.006
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0290.006/6

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0290.006

Cite this Item

Full citation
"Women and HIV Infection." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0290.006. University of Michigan Library Digital Collections. Accessed June 22, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.